Logo image
Sign in
Review of the safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study
Journal article   Peer reviewed

Review of the safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study

Marc S. Rendell and S. G. Chrysant
Postgraduate Medicine, Vol.123(4), pp.183-186
2011
PMID: 21681003

Metrics

5 Record Views

Details